You have just started a new treatment or switched protocols, and the question is immediate: is it working? The honest answer is that you will not know for months, and the way you track during those months determines whether you end up with actionable data or just anxiety. Treatment changes are the single most important period to track with precision, because they represent a controlled variable shift in an otherwise slow-moving biological system. BaldingAI is designed specifically for these inflection points, letting you capture a baseline before you start and then measure objectively against it as your scalp responds. This post covers how to set up that baseline, what to expect in the first weeks and months, and how to interpret the data for different treatment types.
TL;DR
- Establish a multi-scan baseline over 7-10 days before starting any new treatment to account for day-to-day variance.
- Initial shedding (dread shed) is common with finasteride and minoxidil and often indicates the treatment is affecting follicle cycling, not that it is failing.
- Expected response timelines differ by treatment: minoxidil 2-4 months, finasteride 3-6 months, microneedling 6-8 weeks (with adjuncts).
- When stacking treatments, change only one variable at a time and space new additions at least 8 weeks apart to isolate effects.
- A density change of 0.5 points or more sustained over 8+ weeks is statistically meaningful; smaller short-term fluctuations are noise.
Important
This article is educational and not medical advice. If you are worried about sudden shedding, scalp symptoms, or side effects, talk to a licensed clinician.
Why baseline quality determines everything
A single scan on the day you start treatment is better than nothing, but it is a weak baseline. Your density score on any given day is influenced by variables that have nothing to do with your treatment: how recently you washed your hair, whether you slept on one side, minor lighting differences, even scalp hydration. A robust baseline requires multiple scans over 7 to 10 days before you take your first dose or apply your first topical. Three to four scans during that window, taken under consistent conditions, give you a baseline average and a variance range. That variance tells you how much natural fluctuation to expect, so you can distinguish real treatment effects from noise later.
Think of it like a clinical trial’s run-in period. Researchers do not compare a single pre-treatment measurement to a single post-treatment measurement. They establish a baseline distribution and compare post-treatment values against it. The baseline preparation protocol is where most self-trackers cut corners, and it is the single biggest source of misinterpreted results.
Document your current routine in detail alongside the baseline: all products you use on your scalp, wash frequency, any supplements, and your general health status. If you are stacking treatments later, this log becomes essential for isolating which change produced which effect.
The shedding phase: why temporary loss is often a positive signal
Within the first two to eight weeks of starting minoxidil or finasteride, many users experience increased hair shedding. This phenomenon, sometimes called “dread shed,” triggers panic. It looks and feels like the treatment is making things worse. But the mechanism behind it is well understood, and in most cases it is a sign that the treatment is doing exactly what it should.
Minoxidil accelerates the transition of resting telogen follicles into active anagen. When a follicle re-enters anagen, it sheds the old telogen club hair to make room for the new growth. This synchronized shift pushes a larger-than-normal number of hairs into shedding simultaneously. The 1986 study by Headington in Archives of Dermatology first characterized this telogen-release mechanism. The shed hairs were going to fall out eventually; minoxidil simply accelerated the timeline by pushing dormant follicles back into growth earlier.
Finasteride operates differently but can produce a similar early shed. By reducing dihydrotestosterone (DHT) levels by approximately 70%, finasteride alters the hormonal environment around follicles that were being slowly miniaturized. Some of these follicles reset their cycle, shedding the current weakened hair and beginning to produce a thicker replacement. A 2004 review by Sinclair in Clinical Interventions in Aging noted that early shedding on finasteride typically resolved by months three to four, followed by stabilization or improvement.
In your tracking data, the shedding phase appears as a temporary dip in density scores, typically 0.3 to 0.8 points below baseline. If you do not know this is coming, the data looks alarming. If you do, it becomes a predictable phase you can annotate in your tracking log and watch for the expected recovery.
Treatment-specific response timelines
Every treatment has its own biological clock, and mismatching your evaluation window to that clock is how people abandon effective treatments prematurely.
Finasteride (oral, 1 mg daily): The finasteride response timeline spans months, not weeks. Serum DHT drops within days of the first dose, but follicular response lags significantly. Kaufman et al. (1998) in the Journal of the American Academy of Dermatology reported that hair count improvements were measurable at six months and continued to increase through 24 months of treatment. Do not evaluate finasteride before month six. A stable or slightly improving density score at month six is a positive outcome, even if you do not see dramatic visual improvement in the mirror.
Minoxidil (topical, 5%): Response is typically faster than finasteride. The vasodilatory and follicle-stimulating effects begin producing visible new growth in many users by month two to four. Olsen et al. (2002) in the Journal of the American Academy of Dermatology showed significant improvement in non-vellus hair counts by week 16. Expect the shedding phase in weeks two through six, stabilization by month two, and measurable improvement by month four. If your density scores are not trending upward by month six, you may be a non-responder (approximately 40% of users do not respond meaningfully to minoxidil, often due to low sulfotransferase enzyme activity).
Microneedling (0.5-1.5 mm, weekly to biweekly): Microneedling stimulates wound-healing pathways that upregulate growth factors including VEGF, PDGF, and Wnt signaling molecules in the dermal papilla. Dhurat et al. (2013) demonstrated that microneedling combined with minoxidil produced statistically superior results compared to minoxidil alone by week 12. As a standalone treatment, expect slower timelines: 6 to 8 weeks for initial measurable changes, with continued improvement through month six. Track at the same scalp zones each session, and photograph before each microneedling session (not immediately after, when erythema can affect scan accuracy).
Low-level laser therapy (LLLT): Clinical data is more variable, but a 2014 meta-analysis by Afifi et al. in the Journal of the American Academy of Dermatology found significant increases in hair density after 16 to 26 weeks of treatment. Set your evaluation window at six months minimum.
How to isolate treatment effects when stacking
Many people do not use a single treatment. A common stack might include finasteride, minoxidil, microneedling, and a ketoconazole shampoo. If you start all four simultaneously, you have no way to know which one is contributing to any observed improvement or decline. You have introduced four variables at once into an uncontrolled experiment.
The better approach borrows from experimental design: change one variable at a time and space new additions at least eight weeks apart. Start with the treatment most likely to produce the largest effect (typically finasteride or minoxidil). Track for eight to twelve weeks to establish your response curve. Then add the next treatment and continue tracking. If your density scores were stable on treatment A alone and begin improving after adding treatment B, you can attribute the improvement to B with reasonable confidence.
This is not always practical. Some dermatologists prescribe combination therapy from day one, and there are clinical arguments for doing so. In that case, track the combination as a single intervention. You will not know which component is doing the heavy lifting, but you will know whether the overall protocol is working. If you later need to drop one component (due to side effects, cost, or convenience), your continued tracking will reveal whether the remaining treatments are sufficient to maintain your results.
What counts as statistically meaningful improvement
Not every upward tick in your density score means your treatment is working. Normal scan-to-scan variance from lighting, hair state, and follicle cycling can produce fluctuations of 0.2 to 0.4 points on a 0-10 scale. To distinguish signal from noise, you need both magnitude and duration.
A sustained improvement of 0.5 points or more over eight or more weeks, measured at the same scalp zone under consistent conditions, is a meaningful signal. Two consecutive scans showing improvement could be noise. Four or more scans over two months showing a consistent upward trend is data. The clinical analogy is how researchers define treatment response in hair loss trials: Kaufman et al. used serial macrophotography to count hairs in a defined target area at each visit, and only differences that persisted across multiple timepoints were reported as statistically significant.
Conversely, a single scan showing a drop does not mean your treatment has stopped working. Before concluding that a treatment has failed, you need to see a consistent downward trend over at least two to three months. One bad scan is an outlier. Three months of declining scores is a pattern that warrants a conversation with your clinician.
Structuring your tracking during treatment changes
The ideal tracking protocol during a treatment change is more frequent than maintenance tracking. During the first 12 weeks of a new treatment, scan weekly instead of biweekly. This higher frequency gives you enough data points to detect the shedding phase, identify the stabilization point, and catch the early trend of improvement or non-response. After the initial 12-week period, you can reduce to biweekly or monthly scans.
Keep a simple treatment log alongside your scans. Record the date you started, the specific product and dosage, any missed applications or doses, and any side effects. If you are using BaldingAI, tag each scan with the active treatment protocol. When you review your data at the six-month mark, this log turns raw density numbers into a narrative: “Started minoxidil 5% on March 1, experienced shedding phase weeks 2-5, scores stabilized by week 8, upward trend began at week 12, density improved 0.7 points by month six.” That narrative is clinical-grade tracking data.
Mark the treatment start date clearly in your tracking timeline. Every future analysis will reference that date as the intervention point. If you later add a second treatment, mark that date too. Your 12-month dataset becomes a map of interventions and responses that gives you and your dermatologist a clear picture of what works for your specific pattern of androgenetic alopecia.
When to escalate
Tracking data does not just tell you when something is working. It tells you when it is not, and that information is equally valuable. If your density scores show no improvement or continued decline after the expected response window for your treatment (six months for finasteride, four months for minoxidil), that is an evidence-based reason to revisit your protocol. Options at that point include increasing minoxidil concentration (from 2% to 5%, or switching to oral), adding a DHT blocker if you are not already on one, incorporating microneedling, or considering dutasteride for stronger 5-alpha-reductase inhibition.
The key insight is that escalation decisions should be driven by data, not by frustration at month two. Hair biology does not move at the speed of human impatience. Give each treatment its full evaluation window, track through it with discipline, and let the trend line guide your next move.
Track your treatment response
BaldingAI captures your baseline and measures density changes across weeks and months so you know if your treatment is working.
Your scans stay private. Delete or export anytime.
Sources: Kaufman et al. 1998, Journal of the American Academy of Dermatology, Olsen et al. 2002, Journal of the American Academy of Dermatology, Dhurat et al. 2013, International Journal of Trichology.
